---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-253563"
form_type: "8-K"
ticker: "QTTB"
cik: "0001661998"
company_name: "Q32 Bio Inc."
filed_at: "2023-10-10T23:59:59+00:00"
generated_at: "2026-06-10T02:29:24.789177+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Homology Medicines posts corporate slides; no material new information disclosed

## Summary
- Company posted a corporate slide presentation on its investor relations website on October 10, 2023.
- Presentation attached as Exhibit 99.1; no specific financial or operational updates provided in the filing.
- No earnings, guidance, or material events announced; presentation content not detailed in the 8-K.

## SEC filing metadata
- accession: 0001193125-23-253563
- form_type: 8-K
- ticker: QTTB
- cik: 0001661998
- company_name: Q32 Bio Inc.
- filed_at: 2023-10-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661998/000119312523253563/0001193125-23-253563-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661998/000119312523253563/d544025d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-253563
- JSON: https://secwatch.observer/filing/0001193125-23-253563.json
- Plain text: https://secwatch.observer/filing/0001193125-23-253563.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.